Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1D | P28221 | 10/20 | 0.65 |
| ▸ | HTR1E | P28566 | 2/20 | 0.62 |
| ▸ | HTR1A | P08908 | 1/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | NOS3 | P29474 | 2/20 | 0.44 |
| ▸ | NOS1 | P29475 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8990483 | 0.91 | HTR1D (0.67) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL9253801 | 0.90 | HTR1D (0.65) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL8990439 | 0.89 | HTR1D (0.82) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL9163214 | 0.88 | HTR1D (0.63) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL9160928 | 0.87 | HTR1D (0.64) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL8990411 | 0.85 | HTR1D (0.60) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL9166018 | 0.84 | HTR1D (0.83) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL9163972 | 0.84 | HTR1D (0.75) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL8990392 | 0.83 | HTR1D (0.57) | HTR1DHTR1EHTR1ASLC6A2NOS3 | |
| SCHEMBL9166041 | 0.83 | HTR1D (0.64) | HTR1DHTR1EHTR1ASLC6A2NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0666258-A1 | Indolylcycloaklanylamin- und Indolylcycloalkenylamine derivatives, their preparation and their use as anti-migraine agents | Bristol-Myers Squibb Company (US) | 1995-08-09 | — | — | EP | disclosed |